Joseph R. Moskal
Corporate Officer/Principal bij Northwestern University
Profiel
Joseph R.
Moskal was the founder of Naurex, Inc. (founded in 2006) and Aptinyx, Inc. (founded in 2015), where he held the title of Chief Scientific Officer.
He is currently the Director-Falk Center for Molecular Therapeutics at Northwestern University since 2013.
Previously, he worked as the Director-Neurosurgery Laboratories at Albert Einstein College of Medicine, Inc. Dr. Moskal completed his undergraduate and doctorate degrees at the University of Notre Dame.
Actieve functies van Joseph R. Moskal
Bedrijven | Functie | Begin |
---|---|---|
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | - |
Eerdere bekende functies van Joseph R. Moskal
Bedrijven | Functie | Einde |
---|---|---|
Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
APTINYX | Oprichter | - |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Oprichter | - |
Opleiding van Joseph R. Moskal
University of Notre Dame | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
APTINYX | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |